CDKN1A and age-related macular degeneration: Although it increased cellular metabolism and decreased ROS levels in AMD cybrids, this treatment increased levels of IL6 and CASP3 in AMD cybrids and modulated senescence-related genes (CDKN1A and LMNB1) in AMD, KC, and GLc cybrids.